Literature DB >> 20523838

A case of erythroplasia of queyrat treated with imiquimod 5% cream and excision.

Jee Woong Choi1, Mira Choi, Kwang Hyun Cho.   

Abstract

Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion.

Entities:  

Keywords:  Erythroplasia of Queyrat; Imiquimod

Year:  2009        PMID: 20523838      PMCID: PMC2861276          DOI: 10.5021/ad.2009.21.4.419

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  13 in total

1.  Erythroplasia of queyrat: coinfection with cutaneous carcinogenic human papillomavirus type 8 and genital papillomaviruses in a carcinoma in situ.

Authors:  U Wieland; S Jurk; S Weissenborn; T Krieg; H Pfister; A Ritzkowsky
Journal:  J Invest Dermatol       Date:  2000-09       Impact factor: 8.551

2.  Carcinoma arising in Bowen's disease.

Authors:  G F Kao
Journal:  Arch Dermatol       Date:  1986-10

3.  Erythroplasia of Queyrat. A clinicopathologic and histochemical study.

Authors:  J H Graham; E B Helwig
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

4.  Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot study.

Authors:  Manon van Seters; Guus Fons; Marc van Beurden
Journal:  J Reprod Med       Date:  2002-09       Impact factor: 0.142

5.  Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy.

Authors:  G I Stables; M R Stringer; D J Robinson; D V Ash
Journal:  Br J Dermatol       Date:  1999-03       Impact factor: 9.302

6.  Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.

Authors:  Hiroaki Hemmi; Tsuneyasu Kaisho; Osamu Takeuchi; Shintaro Sato; Hideki Sanjo; Katsuaki Hoshino; Takao Horiuchi; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

Review 7.  Topical imiquimod: a review of its use in genital warts.

Authors:  C M Perry; H M Lamb
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 8.  Imiquimod applied topically: a novel immune response modifier and new class of drug.

Authors:  R L Miller; J F Gerster; M L Owens; H B Slade; M A Tomai
Journal:  Int J Immunopharmacol       Date:  1999-01

Review 9.  Cancers, precancers, and pseudocancers on the male genitalia. A review of clinical appearances, histopathology, and management.

Authors:  G R Mikhail
Journal:  J Dermatol Surg Oncol       Date:  1980-12

10.  Importance of human papillomaviruses for the development of skin cancer.

Authors:  T Meyer; R Arndt; E Christophers; I Nindl; E Stockfleth
Journal:  Cancer Detect Prev       Date:  2001
View more
  4 in total

Review 1.  [Dermatological diseases of the external male genitalia : Part 2: Infectious and malignant dermatological].

Authors:  F M Köhn; D Schultheiss; K Krämer-Schultheiss
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

Review 2.  [Dermatological diseases of the male genital tract].

Authors:  F-M Köhn
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

3.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

4.  Development of imiquimod-loaded mucoadhesive films for oral dysplasia.

Authors:  Sandeep K Ramineni; Larry L Cunningham; Thomas D Dziubla; David A Puleo
Journal:  J Pharm Sci       Date:  2012-11-28       Impact factor: 3.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.